Acadia Healthcare (NASDAQ:ACHC) Downgraded by StockNews.com to “Sell”

Acadia Healthcare (NASDAQ:ACHC) was downgraded by investment analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Tuesday.

Several other brokerages have also recently commented on ACHC. TheStreet upgraded shares of Acadia Healthcare from a “c” rating to a “b-” rating in a research report on Monday, March 4th. Royal Bank of Canada reiterated an “outperform” rating and issued a $94.00 price objective on shares of Acadia Healthcare in a report on Monday, March 4th. Deutsche Bank Aktiengesellschaft upgraded Acadia Healthcare from a “sell” rating to a “hold” rating and set a $70.00 target price on the stock in a report on Thursday, April 25th. Barclays lowered their price target on Acadia Healthcare from $91.00 to $89.00 and set an “overweight” rating for the company in a research note on Wednesday, May 15th. Finally, Cantor Fitzgerald reissued a “neutral” rating and set a $90.00 price objective on shares of Acadia Healthcare in a research note on Tuesday, March 5th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and six have issued a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $87.56.

Acadia Healthcare Stock Up 0.7 %

NASDAQ ACHC opened at $66.79 on Tuesday. The company has a debt-to-equity ratio of 0.63, a quick ratio of 1.27 and a current ratio of 1.27. Acadia Healthcare has a 52 week low of $64.74 and a 52 week high of $87.77. The stock has a market capitalization of $6.20 billion, a P/E ratio of -477.04, a price-to-earnings-growth ratio of 1.97 and a beta of 1.31. The stock has a fifty day moving average of $73.38 and a 200-day moving average of $77.10.

Acadia Healthcare (NASDAQ:ACHC) last announced its quarterly earnings data on Thursday, May 2nd. The company reported $0.84 earnings per share for the quarter, topping the consensus estimate of $0.80 by $0.04. The firm had revenue of $768.10 million during the quarter, compared to analysts’ expectations of $779.20 million. Acadia Healthcare had a positive return on equity of 11.49% and a negative net margin of 0.38%. The company’s quarterly revenue was up 9.1% compared to the same quarter last year. During the same period in the previous year, the business posted $0.75 EPS. On average, equities research analysts forecast that Acadia Healthcare will post 3.55 EPS for the current year.

Insiders Place Their Bets

In other Acadia Healthcare news, Director Wade D. Miquelon sold 2,203 shares of the company’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $85.39, for a total transaction of $188,114.17. Following the completion of the transaction, the director now owns 46,074 shares of the company’s stock, valued at approximately $3,934,258.86. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Corporate insiders own 2.00% of the company’s stock.

Institutional Trading of Acadia Healthcare

A number of large investors have recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its stake in Acadia Healthcare by 0.3% in the 4th quarter. Vanguard Group Inc. now owns 8,861,427 shares of the company’s stock valued at $689,065,000 after acquiring an additional 30,296 shares during the period. Wellington Management Group LLP grew its stake in Acadia Healthcare by 2.1% during the third quarter. Wellington Management Group LLP now owns 7,537,922 shares of the company’s stock worth $529,991,000 after buying an additional 152,783 shares in the last quarter. William Blair Investment Management LLC increased its holdings in Acadia Healthcare by 0.3% in the 3rd quarter. William Blair Investment Management LLC now owns 3,058,916 shares of the company’s stock valued at $215,072,000 after buying an additional 10,062 shares during the period. Avidity Partners Management LP lifted its holdings in shares of Acadia Healthcare by 61.8% during the 4th quarter. Avidity Partners Management LP now owns 1,156,692 shares of the company’s stock worth $89,944,000 after acquiring an additional 441,692 shares during the period. Finally, Jennison Associates LLC boosted its position in shares of Acadia Healthcare by 26.1% during the 4th quarter. Jennison Associates LLC now owns 1,148,755 shares of the company’s stock worth $89,327,000 after acquiring an additional 238,114 shares in the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.